HLA-B and Scarring: A Taiwanese research group conducted further prospective screening of HLA-B*58:01 allele for allopurinol new users; the result showed a preemptive screening of HLA-B*58:01 to be effective in protecting patients from developing allopurinol-induced SCAR (Ko et al., 2015).